Anhui Huaren Health Pharmaceutical Co., Ltd. (SHE:301408)
14.36
+0.22 (1.56%)
At close: Aug 3, 2026
SHE:301408 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 5,641 | 5,487 | 4,532 | 3,797 | 3,262 | 2,339 |
Revenue Growth | 20.17% | 21.07% | 19.34% | 16.39% | 39.50% | 21.12% |
Gross Profit Gross Profit Growth | 1,924 | 1,850 | 1,466 | 1,155 | 1,057 | 812.4 |
Operating Income Operating Income Growth | 411.41 | 384.69 | 237.65 | 161.47 | 227.66 | 107.19 |
Net Income Net Income Growth | 209.47 | 191.35 | 137.7 | 114.67 | 160.78 | 69.73 |
Earnings Per Share EPS Growth | 0.53 | 0.48 | 0.34 | 0.29 | 0.47 | 0.21 |
EPS Growth | 40.77% | 41.18% | 17.24% | -38.30% | 123.81% | -19.23% |
| Fiscal Year | FY 2025 |
|---|---|
| Period Ending | Dec '25 Dec 31, 2025 |
Pharmaceutical Marketing and Terminal Procurement Pharmaceutical Marketing and Terminal Procurement Growth | 3,394 |
Pharmaceutical Retail Pharmaceutical Retail Growth | 4,006 |
Other Other Growth | 18.91 |
Offset of Business Offset of Business Growth | -2,130 |
Industrial Production Industrial Production Growth | 197.69 |
Total Total Growth | 5,487 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 999.07 | 979.97 | 1,012 | 1,349 | 482.1 | 285.01 |
Total Debt Total Debt Growth | 1,271 | 1,352 | 1,225 | 1,286 | 762.02 | 597.8 |
Net Cash (Debt) Net Cash Growth | -271.83 | -371.57 | -213.43 | 62.53 | -279.92 | -312.8 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -0.68 | -0.93 | -0.53 | 0.16 | -0.82 | -0.94 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 778.41 | 837.18 | 571.76 | 131.37 | 173.84 | 140.82 |
Capital Expenditures CapEx Growth | -136.69 | -155.42 | -163.42 | -221.01 | -104.77 | -33.91 |
Free Cash Flow Free Cash Flow Growth | 641.72 | 681.76 | 408.33 | -89.64 | 69.07 | 106.91 |
Free Cash Flow Growth | 3.20% | 66.96% | - | - | -35.40% | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 34.10% | 33.71% | 32.34% | 30.43% | 32.41% | 34.74% |
Operating Margin | 7.29% | 7.01% | 5.24% | 4.25% | 6.98% | 4.58% |
Pretax Margin | 5.70% | 5.37% | 4.53% | 3.99% | 6.58% | 4.03% |
Profit Margin | 3.71% | 3.49% | 3.04% | 3.02% | 4.93% | 2.98% |
FCF Margin | 11.38% | 12.43% | 9.01% | -2.36% | 2.12% | 4.57% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Dividend Per Share Dividend Per Share Growth | 0.100 | 0.100 | 0.100 | 0.100 |
Dividend Per Share Growth | 0% | 0% | 0% | - |
Dividend Yield | 0.71% | 0.54% | 0.92% | 0.64% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 26.91 | 38.80 | 32.04 | 55.64 | - | - |
P/FCF Ratio | 8.81 | 10.89 | 10.81 | - | - | - |
PS Ratio | 1.00 | 1.35 | 0.97 | 1.68 | - | - |